Lloyd Advisory Services’s Biogen BIIB Stock Holding History

Lloyd Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15	Closed	-$2.75K	–	673
2026 Q1	$2.75K	Buy	+15	New	+$2.76K	﹤0.01%	630
2023 Q4	–	Sell	-2,146	Closed	-$552K	–	162
2023 Q3	$552K	Buy	+2,146	New	+$574K	0.18%	122

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lloyd Advisory Services's BIIB Position: Q2 2026 in Review

Lloyd Advisory Services sold out of Biogen (BIIB) in Q2 2026, closing a stake of 15 shares — an estimated $2.75K sold.

Lloyd Advisory Services first reported a position in BIIB in Q3 2023 and held it in 2 quarters. The position peaked at $552K in Q3 2023. 1,047 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Lloyd Advisory Services reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
Lloyd Advisory Services sold 15 Biogen shares in Q2 2026, an estimated $2.75K.
Lloyd Advisory Services first reported a position in Biogen in Q3 2023 and held it in 2 quarters.
Lloyd Advisory Services's Biogen position peaked at $552K in Q3 2023.
1,047 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.